Molecular mechanisms of antibiotic resistance in Gram-positive and Gram-negative bacteria - a narrative review
Lariocidin, a structurally novel ribosome-targeting lasso peptide with broad-spectrum activity against both Gram-positive and Gram-negative multidrug-resistant pathogens, is presented as an emerging therapeutic scaffold that circumvents resistance mechanisms operating across both bacterial groups.